The Hospital for Special Surgery in New York City has launched the HSS Innovation Center, with the aim to identify and support medical and scientific technological breakthroughs in musculoskeletal care.
The Center, which brings together the people, infrastructure and finances to support the acceleration and commercialization of early stage technologies, will work to bridge the gap between applied research and product development, officials say.
The Center encompasses not only traditional biomedical science and technology products such as implants, medication and biomaterials, but also new care delivery innovations including process innovations, digital health solutions, wearable technology and telemedicine.
From the portfolio of innovations that include 12 different categories, two examples of technology that is being supported by the HSS Innovation Center include:
- Hydrogel Technology: Physicians and scientists at HSS have developed a portfolio of novel hydrogel biomaterials that will restore damaged joint tissues, thereby preventing or slowing the onset of osteoarthritis. Initial products include an osteochondral implant and total meniscus repair solution that use solid, porous, and fiber embedded hydrogel scaffolds to fully restore the mechanics of the knee.
- Orthosecure: SanDance Technology has partnered with HSS in the creation of OrthoSecure, a web-based application service that helps reduce the occurrence of medical implant errors, reduce implant wastage, and streamline OR workflow, leading to better patient care and greater efficiency.
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.